|
Name |
3-Methyl-1-pentanol
|
Molecular Formula | C6H14O | |
IUPAC Name* |
3-methylpentan-1-ol
|
|
SMILES |
CCC(C)CCO
|
|
InChI |
InChI=1S/C6H14O/c1-3-6(2)4-5-7/h6-7H,3-5H2,1-2H3
|
|
InChIKey |
IWTBVKIGCDZRPL-UHFFFAOYSA-N
|
|
Synonyms |
3-METHYL-1-PENTANOL; 3-Methylpentan-1-ol; 589-35-5; 3-Methylpentanol; 2-Ethyl-4-butanol; 3-Ethyl-1-butanol; 1-Pentanol, 3-methyl-; FEMA No. 3762; N8W93SI0FS; (+/-)-3-methyl-1-pentanol; NSC-9466; 20281-83-8; UNII-N8W93SI0FS; NSC9466; 3-methyl pentanol; NSC 9466; EINECS 209-644-9; MFCD00002937; 3-methyl pentan-1-ol; 3-Methyl-pentan-1-ol; AI3-38563; SCHEMBL14990; 3-Methyl-1-pentanol, 99%; SCHEMBL8988208; CHEBI:87381; DTXSID20862248; 3-Methyl-(.+/-.)-1-Pentanol; (DL)-3-METHYLPENTYL ALCOHOL; LMFA05000111; 3-Methyl-1-pentanol, >=99%, FG; AKOS009156537; 3-METHYL-1-PENTANOL, 97%,; SB83830; 1-Pentanol, 3-methyl-, (.+/-.)-; BS-23125; DB-050838; CS-0204814; FT-0616038; FT-0639759; M0600; D91364; EN300-140256; A869318; Q3278324; 343268-11-1
|
|
CAS | 589-35-5 | |
PubChem CID | 11508 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 102.17 | ALogp: | 1.8 |
HBD: | 1 | HBA: | 1 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 20.2 | Aromatic Rings: | 0 |
Heavy Atoms: | 7 | QED Weighted: | 0.577 |
Caco-2 Permeability: | -4.143 | MDCK Permeability: | 0.00002810 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.063 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.007 |
30% Bioavailability (F30%): | 0.015 |
Blood-Brain-Barrier Penetration (BBB): | 0.981 | Plasma Protein Binding (PPB): | 33.81% |
Volume Distribution (VD): | 1.176 | Fu: | 60.40% |
CYP1A2-inhibitor: | 0.382 | CYP1A2-substrate: | 0.771 |
CYP2C19-inhibitor: | 0.045 | CYP2C19-substrate: | 0.649 |
CYP2C9-inhibitor: | 0.03 | CYP2C9-substrate: | 0.358 |
CYP2D6-inhibitor: | 0.006 | CYP2D6-substrate: | 0.134 |
CYP3A4-inhibitor: | 0.011 | CYP3A4-substrate: | 0.203 |
Clearance (CL): | 9.376 | Half-life (T1/2): | 0.775 |
hERG Blockers: | 0.019 | Human Hepatotoxicity (H-HT): | 0.03 |
Drug-inuced Liver Injury (DILI): | 0.036 | AMES Toxicity: | 0.007 |
Rat Oral Acute Toxicity: | 0.034 | Maximum Recommended Daily Dose: | 0.036 |
Skin Sensitization: | 0.393 | Carcinogencity: | 0.254 |
Eye Corrosion: | 0.984 | Eye Irritation: | 0.992 |
Respiratory Toxicity: | 0.092 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001474 | 0.571 | D00AMQ | 0.263 | ||||
ENC000307 | 0.571 | D0Y3KG | 0.257 | ||||
ENC000600 | 0.500 | D0C1QZ | 0.250 | ||||
ENC001246 | 0.441 | D0ZK8H | 0.226 | ||||
ENC000182 | 0.435 | D08QME | 0.217 | ||||
ENC000311 | 0.424 | D00WUF | 0.211 | ||||
ENC000768 | 0.419 | D0EP8X | 0.200 | ||||
ENC000503 | 0.419 | D0M1PQ | 0.189 | ||||
ENC000554 | 0.406 | D02KBD | 0.180 | ||||
ENC001596 | 0.390 | D0X2IE | 0.179 |